Stereotactic Body Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer-Is This the Future?

Affiliations

¹ Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington.
² Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut.

Comment

Nataniel H Lester-Coll et al. JAMA Oncol. 2024.

. 2024 Mar 1;10(3):360-361.

doi: 10.1001/jamaoncol.2023.5856.

¹ Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington.
² Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut.

No abstract available

Comment on

Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Wu TC, Luterstein E, Neilsen BK, Goldman JW, Garon EB, Lee JM, Felix C, Cao M, Tenn SE, Low DA, Kupelian PA, Steinberg ML, Lee P. Wu TC, et al. JAMA Oncol. 2024 Mar 1;10(3):352-359. doi: 10.1001/jamaoncol.2023.6033. JAMA Oncol. 2024. PMID: 38206614 Free PMC article.

Bronchial arterial chemoembolization/infusion combined with iodine-125 brachytherapy in advanced non-small cell lung cancer: a promising salvage therapy after standard treatment failure.
Tang F, Cao XJ, Gong T, Huang XY, Ya-Qing K, Xiang Z. Tang F, et al. BMC Cancer. 2025 Apr 22;25(1):750. doi: 10.1186/s12885-025-13949-9. BMC Cancer. 2025. PMID: 40264073 Free PMC article.